OptimizeRx
OPRX
53 hedge funds and large institutions have $110M invested in OptimizeRx in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 8 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 11
52% more capital invested
Capital invested by funds: $72.4M → $110M (+$37.8M)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
11% more call options, than puts
Call options by funds: $625K | Put options by funds: $563K
4% more funds holding
Funds holding: 51 → 53 (+2)
3.15% more ownership
Funds ownership: 54.62% → 57.76% (+3.1%)
Top Buyers
Top Sellers
OPRX Hedge Fund Activity: Q2 2020 in Review
53 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2020, worth a combined $110M — up 52% from $72.4M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new OPRX positions and 8 closed out — a net gain of 3 holders — while 22 added to existing stakes and 11 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $6.41M. The largest seller was Park West Asset Management, exiting entirely with an estimated $6.17M sold.
- 53 institutional investors held OptimizeRx (OPRX) as of Q2 2020, up from 51 in Q1 2020.
- Funds reported $110M of OptimizeRx stock for Q2 2020, up 52% quarter-over-quarter.
- 11 funds opened new OptimizeRx positions in Q2 2020 and 8 closed out, a net change of +3 holders.
- The largest OptimizeRx buyer in Q2 2020 was First Light Asset Management, an estimated $6.41M added.
- The largest OptimizeRx seller in Q2 2020 was Park West Asset Management, an estimated $6.17M sold.
Based on aggregated 13F filings for Q2 2020.